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CASE 2
A 72-year-old man presented with advanced renal cell carcinoma, metastatic to the sternum. After cytoreductive right nephrectomy, treatment with low-dose IFN was initiated at 0.5 million units subcutaneously twice daily on protocol. After 10 months of IFN therapy, subacute central visual loss in the left eye was described. Visual acuity measured 20/25 in the right eye and count fingers in the left eye. Fundoscopic examination demonstrated disc edema with associated hemorrhage in the left eye. A left-sided centrocecal scotoma was detected on Humphrey visual field testing. Comprehensive neurologic and serologic evaluation demonstrated no abnormalities. IFN was discontinued and a tapering course of steroids was started but the patient failed to recover his baseline visual acuity.
DISCUSSION
Ocular side effects secondary to IFN are uncommon. Most cases of decreased vision are transient, although permanent decline of vision has been reported. Ischemic changes have been demonstrated on fluorescein angiography. Permanent vision loss secondary to optic nerve edema, optic neuritis, and bilateral ischemic optic neuropathy have been reported in patients who received high-dose IFN as adjuvant therapy for high-risk melanoma. 1 Our report demonstrates that optic neuritis may also occur in patients who receive low-dose IFN. Although the pathophysiology of IFN-associated anterior ischemic optic neuropathy remains unclear, an underlying immunologic mechanism is suggested. It has been postulated that IFN is able to produce autoantibodies leading to the deposition of immune complexes in the small retinal or optic arteries. 2 IFN also has immunomodulatory properties capable of stimulating the production of other cytokines, such as various interleukins, and up-regulating histocompat-ibility complex class II proteins. 3 These interleukins can cause an inflammatory response affecting the blood vessels, leading to ischemia. It has also been proposed that IFN causes systemic hypotension, which may lead to optic vascular ischemia. 4 
